Skip to main content
Log in

Lokale Metastasentherapie bei oligometatasierten Karzinomen

Ein spannendes Thema auch beim Prostatakarzinom

Local metastasis treatment in oligometastatic disease

Also relevant for prostate cancer

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. van den Bergh RC, van Casteren NJ, van den Broeck T et al (2016) Role of hormonal treatment inprostate cancer patients with nonmetastatic disease recurrence after local curative treatment: a systematic review. Eur Urol 69:802–820

    Article  PubMed  Google Scholar 

  2. De Bruycker A, Lambert B, Claeys T et al (2017) Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy. BJU Int 120:815–821

    Article  PubMed  Google Scholar 

  3. Gomez DR, Blumenschein GR, Lee JJ et al (2016) Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol 17:1672–1682

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13:8–10

    Article  CAS  PubMed  Google Scholar 

  5. Ost P, Bossi A, Decaestecker K et al (2015) Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature. Eur Urol 67:852–863

    Article  PubMed  Google Scholar 

  6. Ost P, Reynders D, Decaestecker K et al (2017) Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial. J Clin Oncol. https://doi.org/10.1200/JCO.2017.75.485

    PubMed  Google Scholar 

  7. Parker WP, Davis BJ, Park SS et al (2017) Identification of site-specific recurrence following primary radiation therapy for prostate cancer using C‑11choline positron emission tomography/computed tomography: a nomogram for predicting extrapelvic disease. Eur Urol 71:340–348

    Article  PubMed  Google Scholar 

  8. Sobol I, Zaid HB, Haloi R et al (2017) Contemporary mapping of post-prostatectomy prostate cancer relapse with (11)C-choline positron emission tomography and multiparametric magnetic resonance imaging. J Urol 197:129–134

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jürgen Dunst.

Ethics declarations

Interessenkonflikt

J. Dunst und R. Baumann geben an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation

Ost P, Reynders D, Decaestecker K et al (2017) Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial. J Clin Oncol. https://doi.org/10.1200/JCO.2017.75.4853

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dunst, J., Baumann, R. Lokale Metastasentherapie bei oligometatasierten Karzinomen. Strahlenther Onkol 194, 465–467 (2018). https://doi.org/10.1007/s00066-018-1284-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-018-1284-4

Navigation